Cardiol Therapeutics Inc (TSX: CRDL )
2.680
-0.080
(-2.90%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Press Releases about Cardiol Therapeutics IncVia TheNewswire.com
Exposures
Product Safety
Via Newsfile
Cardiol Therapeutics Granted Orphan Drug Designation for its Lead Drug Candidate for the Treatment of Pericarditis
February 15, 2024
Via Newsfile
Exposures
Product Safety
Via Newsfile
Cardiol Therapeutics On Track To Provide New Standard Of Care For Cardiovascular Diseases ($CRDL)
October 10, 2023
Via AB Newswire
Topics
Stocks
Exposures
US Equities
Via Newsfile
Air Pollution is a Global Heart and Lung Health Concern
July 18, 2022
![]()
Why Orphan Drug Designation Offers Several Benefits
May 18, 2022
Exposures
Product Safety
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|